EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological characteristics and prognosis in ovarian metastatic tumors from non-gynecologic primary sites

Türk Jinekolojik Onkoloji Dergisi · 2023

DOI: 10.59215/trsgo.1282732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Türk Jinekolojik Onkoloji Dergisi, 2023.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate clinicopathological characteristics and prognosis in ovarian metastatic tumors from non-gynecologic primary sites.Materials and methods: This study was a retrospective trial enrolling consecutive patients with ovarian metastasis from non-gynecologic primary sites, either diagnosed synchronous or metachronously, who underwent surgery at a single institution between January 2015 and December 2021. Clinicopathological characteristics of patients were extracted from patients’ charts and electronic database; and analyzed using Cox proportional hazard models.

Results

Of the 291 malignant ovarian tumors that underwent surgery, 33 (11.3%) had a diagnosis of ovarian metastasis from non-gynecologic primary sites. The most common primary tumor sites were colorectum (45.5%), stomach (15.2%), and breast (12.1%). Most of the patients exhibited elevated preoperative serum Ca-125 levels (71.4%); roughly half of the patients had syncronous ovarian metastases (48.5%); and approximately one third had peritoneal involvement (36.4%) and/or ascites (30.3%). A complete resection (R0) was achieved in 72.0% of the patients. The median follow-up time was 15.5 months, ranging from 2 to 85 months. The median overall survival (OS) was 41 months with estimated 18-, 24- and 36-month OS rates of 60.1%, 56.1% and 50.5%, respectively. Age (>45 years; hazard ratio (HR): 3.199; 95% confidence interval (CI): 0.899 – 11.380) and presence of ascites (HR: 4.109, 95% CI: 1.436 – 11.757) were independent predictors of OS.

Conclusion

In ovarian metastatic tumors from non-gynecologic primary sites, age and the presence of ascites are the main determinants of prognosis, while no survival benefit of cytoreductive surgery was demonstrated.

Zitieren

APA

(2023). Clinicopathological characteristics and prognosis in ovarian metastatic tumors from non-gynecologic primary sites. Türk Jinekolojik Onkoloji Dergisi. https://doi.org/10.59215/trsgo.1282732

Vancouver

Clinicopathological characteristics and prognosis in ovarian metastatic tumors from non-gynecologic primary sites. Türk Jinekolojik Onkoloji Dergisi. 2023. doi:10.59215/trsgo.1282732

BibTeX
@article{euvimed2023,
  title = {Clinicopathological characteristics and prognosis in ovarian metastatic tumors from non-gynecologic primary sites},
  journal = {Türk Jinekolojik Onkoloji Dergisi},
  year = {2023},
  doi = {10.59215/trsgo.1282732}
}
Kostenlos starten →